In March 2025, the company announced new ideas for a direct-to-purchaser giving of its Wegovy weight loss drug. The company established a whole new pharmacy, called NovoCare, which would charge consumers $499 per 30 days for entry to the drug, below half the expense of the drug via other pharmaceutical distribution networks.[53]Novo Nordisk is link